2 years ago

Lightcast Discovery Secures $49 Million Series B to Advance Single-Cell Functional Analysis Platform

  • Lightcast Discovery, a Cambridge, UK-based life science tools company, raised $49 million in Series B funding led by M Ventures

  • The company plans to use the funds for growth and expansion ahead of its commercial launch

  • Lightcast's technology enables the manipulation of addressable picolitre droplets with light in a massively parallel manner, enabling sequential assays beyond transcriptome-only readouts.

      • ProblemTechnology

      "Current single-cell analysis methods are limited in their ability to provide comprehensive functional insights, often focusing solely on transcriptome readouts and lacking the flexibility to handle diverse cell types and assays."

      Solution

      "Lightcast Discovery offers a novel single-cell functional analysis platform that leverages light-based manipulation of addressable picolitre droplets. This enables sequential assays beyond transcriptome-only readouts, allowing for a deeper understanding of cell function."

      Covered on